Suppression of stimulated plasma renin by clonidine in the dog.
- 1 March 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 2 (2) , 187-191
- https://doi.org/10.1161/01.hyp.2.2.187
Abstract
The mechanism by which clonidine suppresses plasma renin activity (PRA) was investigated in dogs anesthetized with pentobarbital. Injection of clonidine (1 micrograms/kg) into the cisterna magna decreased PRA from levels stimulated by prior hemorrhage into a blood reservoir to reduce mean blood pressure by 25% (21.7 ng/ml/hr +/- 6.6 SE leads to 11.1 ng/ml/hr +/- 2.4 SE; p less than 0.05). Clonidine reduced heart rate but mean arterial pressure remained constant due to fluid movement between the reservoir and the arterial circulation of the dog. These effects could not be attributed to leakage of clonidine from the cerebrospinal fluid since intravenous administration of the same dose had no effect on PRA. In animals bilaterally splanchnicotomized at the level of the diaphragm, elevated PRA was not reduced by intracisternal clonidine. When return of reservoir fluid was prevented, animals became hypotensive after central clonidine and renin tended to increase. These results indicate that clonidine reduces stimulated renin by a central mechanism that is dependent upon the integrity of the sympathetic innervation of the kidney. Other stimuli for renin release may override the inhibitory effect of central clonidine.This publication has 9 references indexed in Scilit:
- Effect of Spinal Cord Transection on the Endocrine and Blood Pressure Responses to Intravenous ClonidineNeuroendocrinology, 1978
- Evidence for a renal alpha-adrenergic receptor inhibiting renin release.Circulation Research, 1976
- Mechanisms regulating renin releasePhysiological Reviews, 1976
- Evidence for a renal vascular receptor in control of renin secretionAmerican Journal of Physiology-Legacy Content, 1971
- Suppression of Renin and Aldosterone by Clonidine.Annals of Internal Medicine, 1971
- Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patientsEuropean Journal of Pharmacology, 1970
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)European Journal of Pharmacology, 1967
- Control of renin release.Physiological Reviews, 1967